Hi there Fangk,
Correct, selling and admin expenses have increased by $4.30m to $12.40m for the half year.
This is no surprise, and has been previously flagged by management, as the increase is attributable to ARX building up their US sales force.
I am expecting the full year sales and admin cost to be around $25m, so a half year figure of $12.40m is on target.
This is basically an investment that will provide high rate of return in future years.
The company will likely be EBITDA positive in 2024.
Good luck
- Forums
- ASX - By Stock
- ARX
- Ann: Aroa Biosurgery Half Yearly Report Update Amendment
Ann: Aroa Biosurgery Half Yearly Report Update Amendment, page-3
Featured News
Add ARX (ASX) to my watchlist
(20min delay)
|
|||||
Last
56.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $193.1M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1380 | 56.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
56.5¢ | 57836 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1380 | 0.560 |
2 | 17626 | 0.550 |
2 | 7222 | 0.540 |
1 | 40000 | 0.535 |
2 | 53773 | 0.530 |
Price($) | Vol. | No. |
---|---|---|
0.565 | 57836 | 5 |
0.570 | 32900 | 3 |
0.575 | 61470 | 2 |
0.580 | 7939 | 2 |
0.595 | 4 | 1 |
Last trade - 09.00am 27/09/2024 (20 minute delay) ? |
Featured News
ARX (ASX) Chart |
Day chart unavailable